View of Beyond Black-Letter Antitrust: Pharmaceutical Patent Expiry, GenericCompetition, and the Rule of Reason in the Pfizer-Dexa Amlodipine Case a Comparative Legal-Systemic Study of Indonesia, the United States, the European Union, and Japan

Return to Article Details Beyond Black-Letter Antitrust: Pharmaceutical Patent Expiry, GenericCompetition, and the Rule of Reason in the Pfizer-Dexa Amlodipine Case a Comparative Legal-Systemic Study of Indonesia, the United States, the European Union, and Japan Download Download PDF